Peplin Receives $24,000,000 New Round

  • Feed Type
  • Date
    8/29/2008
  • Company Name
    Peplin
  • Mailing Address
    6475 Christie Avenue Emeryville, CA 94608
  • Company Description
    Peplin was founded in 1998 to advance promising research undertaken by its founder Dr Jim Aylward. Dr Aylward, utilizing facilities at the Queensland Institute of Medical Research (QIMR), was interested in evaluating the anti-cancer properties of natural products sourced from non-indigenous plants of the genus Euphorbiaceae. In particular Dr Aylward was interested in the science behind the observation that the sap of Euphorbia peplus had enjoyed a history of community use as a treatment for skin cancer conditions.
  • Website
    http://www.peplin.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $24,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    MPM Capital
  • Venture Investor
    New Enterprise Associates

Trending on Xconomy